Nuvation Bio Inc (NUVB)
3.20
+0.21
(+7.02%)
USD |
NYSE |
May 01, 16:00
3.20
0.00 (0.00%)
After-Hours: 18:03
Nuvation Bio Shareholders Equity (Quarterly): 605.12M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 605.12M |
| September 30, 2023 | 611.59M |
| June 30, 2023 | 624.63M |
| March 31, 2023 | 641.07M |
| December 31, 2022 | 655.08M |
| September 30, 2022 | 667.94M |
| June 30, 2022 | 693.08M |
| Date | Value |
|---|---|
| March 31, 2022 | 723.56M |
| December 31, 2021 | 746.00M |
| September 30, 2021 | 769.37M |
| June 30, 2021 | 788.94M |
| March 31, 2021 | 806.34M |
| December 31, 2020 | 215.08M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
215.08M
Minimum
Dec 2020
806.34M
Maximum
Mar 2021
657.52M
Average
667.94M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
| iBio Inc | 9.197M |
| Flora Growth Corp | 6.404M |
| Lixte Biotechnology Holdings Inc | 3.995M |
| Replimune Group Inc | 421.54M |
| ABVC BioPharma Inc | 8.388M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 621.48M |
| Total Liabilities (Quarterly) | 16.36M |